Lawrence Steinman
Fortune : 196 931 $ au 31/05/2026
Fortune : 196 931 $ au 31/05/2026
Lawrence J.
Steinman is the founder of Nuon Therapeutics, Inc. (founded 2006), Neurocrine Biosciences, Inc. (founded 1997) where the title held is Director from 1997 to 2005, Bayhill Therapeutics, Inc. (founded 2001) where the title held is Director from 2010 to 2013, Atreca, Inc. (founded 2012) where the title held is Director from 2012 to 2019, Forum Markets, Inc. (founded 2013) where the title held is Director from 2024 to 2025, and Pasithea Therapeutics Corp.
(founded 2020) where the title held is Executive Chairman.
Dr. Steinman is also the founder of Drumroll Health, Inc.,Steinman Laboratory,Katexco Pharmaceuticals Corp.,Tolerion, Inc....
Current jobs include Co-Chairman at CannBioRex Pharmaceuticals Corp.
since 2018, Co-Chairman at 180 Life Corp.
since 2019, Lead Independent Director at BioAtla, Inc. since 2020, Director at Himalaya Therapeutics, Member at National Academy of Sciences, Member at National Academy of Medicine (United States), Member-Supervisory Board at Pharnext SA since 2023, and Professor at Stanford University since 2011.
Former jobs include Co-Executive Chairman at KBL Merger Corp.
IV, Chairman-Interdepartmental Program at Stanford University School of Medicine from 2003 to 2011, Director at Centocor, Inc. from 1990 to 1998, and Director at Neuronyx, Inc. Education includes an undergraduate degree from Dartmouth College conferred in 1968, a doctorate from Harvard Medical School conferred in 1973, a doctorate from Hasselt University conferred in 2008, and a doctorate from the University of Buenos Aires School of Medicine conferred in 2022.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 01/05/2026 | 199 691 ( 0,6 % ) | 142 779 $ | 31/05/2026 | |
| 12/07/2025 | 11 249 ( 0,08 % ) | 49 833 $ | 31/05/2026 | |
BIOATLA, INC. 0,07 % | 31/03/2026 | 1 099 ( 0,07 % ) | 4 319 $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| BIOATLA, INC. | Directeur/Membre du Conseil | 01/07/2020 |
| PHARNEXT SCA | Directeur/Membre du Conseil | 17/07/2020 |
| PASITHEA THERAPEUTICS CORP. | Fondateur | 12/05/2020 |
Katexco Pharmaceuticals Corp.
Katexco Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Operates as medical marijuana company which develops drugs for treatment of rheumatoid arthritis and inflammatory bowel disease | Fondateur | - |
Stanford University
Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01/01/2001 |
Himalaya Therapeutics
Himalaya Therapeutics Medical/Nursing ServicesHealth Services Provides cancer therapy to patient | Directeur/Membre du Conseil | - |
180 Life Corp.
180 Life Corp. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Président | 14/05/2019 |
National Academy of Sciences
National Academy of Sciences Miscellaneous Commercial ServicesCommercial Services Operates as a private, nongovernmental institution that advises on issues related to science and technology | Corporate Officer/Principal | - |
National Academy of Medicine (United States)
National Academy of Medicine (United States) Miscellaneous Commercial ServicesCommercial Services Operates as a professional membership organization | Corporate Officer/Principal | - |
| ░░░░░░░░░░ ░░░░░░░░░░░░░░░ ░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| Sociétés | Poste | Fin |
|---|---|---|
| ░░░░░ ░░░░░░░░ ░░░░░░░░░░░░ | ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░░ | ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░ | ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░░░░░░░ ░░░░░░ ░░ ░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 26 |
|---|---|
Centocor, Inc.
Centocor, Inc. Medical SpecialtiesHealth Technology Manufactures healthcare products | Health Technology |
Neurocrine Biosciences, Inc.
Neurocrine Biosciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes treatments for neurological, neuroendocrine and neuropsychiatric disorders | Health Technology |
Bayhill Therapeutics, Inc.
Bayhill Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics | Health Technology |
Neuronyx, Inc.
Neuronyx, Inc. Medical SpecialtiesHealth Technology Develops and distributes bone marrow derived stem cells | Health Technology |
Atreca, Inc.
Atreca, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops novel antibody-based immune therapeutics to treat a range of solid tumor cancers | Health Technology |
Dartmouth College
Dartmouth College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Stanford University
Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
National Academy of Sciences
National Academy of Sciences Miscellaneous Commercial ServicesCommercial Services Operates as a private, nongovernmental institution that advises on issues related to science and technology | Commercial Services |
National Academy of Medicine (United States)
National Academy of Medicine (United States) Miscellaneous Commercial ServicesCommercial Services Operates as a professional membership organization | Commercial Services |
Hasselt University
Hasselt University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Nuon Therapeutics, Inc.
Nuon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies to treat inflammation and neurological diseases | Health Technology |
BioAtla, Inc.
BioAtla, Inc. BiotechnologyHealth Technology Develops novel monoclonal antibody and protein therapeutic products | Health Technology |
Pharnext SA
Pharnext SA Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops therapies for patients to treat neurodegenerative diseases | Health Technology |
Harvard Medical School
Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Stanford University School of Medicine
Stanford University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tolerion, Inc.
Tolerion, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics | Health Technology |
University of Buenos Aires School of Medicine
University of Buenos Aires School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
KBL Merger Corp. IV
KBL Merger Corp. IV Financial ConglomeratesFinance Operates as blank check company | Finance |
Drumroll Health, Inc.
Drumroll Health, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in conducting research in biotechnology | Commercial Services |
CannBioRex Pharmaceuticals Corp.
CannBioRex Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Develops novel synthetic pharmaceutical products | Health Technology |
Steinman Laboratory | |
Katexco Pharmaceuticals Corp.
Katexco Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Operates as medical marijuana company which develops drugs for treatment of rheumatoid arthritis and inflammatory bowel disease | Health Technology |
180 Life Corp.
180 Life Corp. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
180 Life Sciences Corp.
180 Life Sciences Corp. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals for chronic pain and inflammatory diseases | Health Technology |
Pasithea Therapeutics Corp.
Pasithea Therapeutics Corp. Pharmaceuticals: MajorHealth Technology Engages in research and development of drugs for mental health disorders | Health Technology |
Himalaya Therapeutics
Himalaya Therapeutics Medical/Nursing ServicesHealth Services Provides cancer therapy to patient | Health Services |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national